4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-20-035104
Director bought 49,125 shares at an average $43.27 ($2,125,795)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…